The experiments performed here show that the targeted nanodiagnostic agent US+IR780@INPs-CTX exhibits good imaging results, combining highly sensitive fluorescence imaging with high spatial resolution MRI, and this continuous treatment system more effective against NSCLC with high EGFR expression, providing new ideas for future clinical diagnosis and treatment programs. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.